title: Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility.
authors.forename: J N
authors.initials: JN
authors.lastname: Fink
authors.forename: M H
authors.initials: MH
authors.lastname: Selim
authors.forename: S
authors.initials: S
authors.lastname: Kumar
authors.forename: G
authors.initials: G
authors.lastname: Schlaug
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018579:Patient Selection; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator